Poseida Therapeutics Announces Strategic Investment By Astellas And Provides Business Update
Round Type
Corporate Round
San DiegoBiotechnologyHealth CareTherapeuticsInvestors
Description
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced a $50 million strategic investment by Astellas, which is comprised of the purchase of 8,333,333 shares of common stock at $3.00 per share for an aggregate purchase price of $25 million and an additional $25 million one-time payment for certain strategic rights, and provided a business update.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Poseida Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- DalCor Pharmaceuticals raised $80M (Series D) on September 13, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Grit Biotechnology raised $60M (Series B) on September 8, 2023.
- Corteria raised $70M (Funding Round) on September 7, 2023.
- Aptose Biosciences raised $3M (Seed) on September 6, 2023.
- Nimbus Therapeutics raised $210M (Funding Round) on September 6, 2023.
Who to call at Poseida Therapeutics, Inc., and when
A new round usually means Poseida Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Poseida Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Poseida Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Poseida Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Poseida Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Poseida Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.